Wedbush analyst Daniel Ives lowered the firm's price target on VMware to $160 from $210 and keeps an Outperform rating on the shares following the company's "mixed" quarterly results, with healthy bookings overshadowed by a top-line miss. The company is going through a major growth transition with execution challenges and worries about taking its eye off the ball over the coming quarters a real worry, Ives tells investors in a research note, adding that while he believes firmly in the strategic vision, margin pressures and slowing growth on its core business will be a headwind for the coming quarters.